top of page


Beyond Square Footage: How $876B Age-in-Place Longevity Real Estate Is Unlocking an $84T Wealth Shift
At the convergence of geroscience venture capital, private equity roll-ups, and ultra-luxury urban development lies Age-in-Place Longevity Real Estate. By embedding non-invasive diagnostic arrays, adaptive universal design, and invisible healthspan tech directly into private fee-simple units—where average resident retention stretches to 12 to 18 years—these developments de-risk tenant turnover to near-zero churn, boost net operating income by 28% to 42% through high-margin he
4 min read


THE HORIZONS Dispatch | Sep - Oct 06
Capital follows vitality. Here is where the global longevity, investment, and high-performance ecosystem meets next.
3 min read


The Horizons Dialogue with Alexandra Beckstein
The Quantum Advantage: Will Quantum Computing Redefine Drug Discovery, Longevity, and Healthcare?
6 min read


Atlas: Decoding the Language of Peak Performance
The brainspan is not a static biological ceiling; it is a dynamic landscape of neural plasticity that can be architected and optimized. In the pursuit of luxury longevity, the modern leader requires more than just passive tracking—they demand an interpretive engine that translates raw physiological data into the precise "language" of peak performance. Atlas represents the vanguard of this interpretive shift, moving us from merely measuring health to actively decoding the com
2 min read


Beyond the Resort: How BEING 2026 Mapped Phuket’s Longevity Pivot
Under the light of Angsana Laguna Phuket, the atmosphere at BEING 2026 felt less like a standard industry gathering and more like a quiet turning point for regional capital. Co-curated by C9 Hotelworks and Delivering Asia, the summit stepped beyond familiar leisure rhetoric to confront a deeper reality unfolding across the island: the fundamental convergence of real estate, clinical medicine, and high-end hospitality.
3 min read


Capitalizing the Sweat Economy: Hyrox and the $1B Rise of Performative Longevity
The Evolution: From Private Diagnostic Labs to Public Arenas
For years, the longevity narrative belonged almost exclusively to clinical diagnostics, pharmaceutical interventions, and quiet metabolic retreats. Millions were poured into measuring VO_2 max, muscle mass retention, and baseline cardiovascular health inside private labs.
Then came Hyrox—and brought the diagnostics out of the clinic and into the arena.
5 min read


The Horizons Dialogue with Marc P. Bernegger
Exploring Longevity Entrepreneurship, Innovation, and Executive Vitality
Complementing this venture-building expertise, Marc is the architect behind the Longevity Investors Conference, the world’s premier private gathering at the intersection of longevity science and capital. While he hosts the exclusive "Longevity Investors Lunch" annually during the World Economic Forum in Davos—a critical platform for high-level dialogue—the flagship Longevity Investors Conference in Gstaa
8 min read


Why Every Longevity Founder Quotes TAM—and Why Serious Investors Care About SOM
As the longevity economy matures into an investable asset class, capital is shifting its attention from market size to enterprise value. Spend enough time reviewing longevity investment decks and a familiar pattern quickly emerges. Almost every founder begins with the same proposition: the longevity economy represents one of the most significant investment opportunities of the twenty-first century. Depending on how its boundaries are defined, the addressable market extends fa
6 min read


Singapore: The World's Leading Experiment in Engineered Healthspan
How policy, urban design and prevention are reshaping the way a nation ages.
When National Geographic Fellow Dan Buettner described Singapore as an "Engineered Blue Zone" in 2023, it challenged the long-held belief that exceptional health and longevity are largely the product of culture, geography or genetics.
Singapore offers a different model. Its success has been shaped through deliberate policy, long-term planning and sustained investment in population
6 min read


THE HORIZONS Dispatch | Aug - Sep 06
Capital follows vitality. Here is where the global longevity, investment, and high-performance ecosystem meets next.
2 min read


The Horizons Dialogue with Anna Bjurstam
Anna Bjurstam is the founder of Wahayla, an independent global wellness and longevity advisory dedicated to advancing the convergence of biological optimization, luxury hospitality, and human experience. An internationally renowned thought leader and strategist, she advises hotel groups, fitness brands, and medical institutions on transitioning from transactional health services to enduring lifestyle ecosystems—reframing the value proposition of physical real estate around se
8 min read


The Brainspan Trend: How Neurotech is Redefining the Architecture of Longevity
The metrics that have defined elite human performance for the past decade are quietly becoming baseline commodities. The global vanguard has spent years meticulously quantifying the vessel—mapping heart rate variability like financial charts, tracking sleep architecture, and measuring glycemic responses to environmental inputs. Yet, as the physical domain becomes increasingly optimized, a profound realization is taking root among those who operate at the absolute limits of pe
4 min read


Flow Neuroscience: Restoring the Cognitive Baseline
The modern executive’s struggle is not merely the presence of stress, but the systemic erosion of the neural pathways that govern emotional resilience and executive focus. True brainspan—the longevity of our cognitive systems—demands a proactive approach to neuro-maintenance that goes beyond traditional talk therapy or pharmacological intervention. Flow Neuroscience represents the definitive institutional-grade solution, utilizing targeted transcranial direct current stimulat
2 min read


Lumia: The Hemodynamic Auditor of Cerebral Health
The brainspan is governed by one fundamental reality: the brain requires a constant, precise supply of oxygenated blood to maintain cognitive coherence. For the global elite, whose performance depends on sustained high-level output, the integrity of this blood flow is the ultimate, non-negotiable infrastructure. Lumia Health represents a paradigm shift in neuro-diagnostics, transforming the ear—a uniquely accessible anatomical window—into a high-fidelity sensor site for track
2 min read


Where Capital Meets Longevity: Insights Ahead of the LONGEVITY INVESTORS CONFERENCE in Gstaad
The field has moved fast. Not long ago longevity was treated as a curiosity; now Longevity's a real investment category, on track to reach $67B by 2035. That shift is the thing worth paying attention to. The good companies aren't selling immortality. They're going after healthspan, treating aging as a root cause, and measuring themselves against clinical results.
6 min read


From Couture to Kinetic Grit: Why LVMH Capital is Backing HYROX to Corner the Performance Class
The border between community endurance and ultra-luxury portfolios has officially dissolved. LVMH Capital, operating through its premier consumer-focused private equity vehicle L Catterton, has entered advanced exclusive negotiations to acquire a dominant majority stake in the global fitness racing phenomenon, HYROX. The deal, which negotiates terms with Switzerland-based sports marketing and rights giant Infront Sports & Media AG, commands a striking market valuation floor b
2 min read


MedTech World Asia and The Hong Kong Convergence: Where Capital, Science, and Longevity Infrastructure Intersect
From August 26 to 28, 2026, the Hong Kong Convention and Exhibition Centre (HKCEC) will become the epicenter of Asia’s evolving healthcare economy as MedTech World Asia 2026 opens its doors.
For global investors, sovereign wealth, and clinical pioneers, this gathering marks a decisive moment in the institutionalization of healthspan technology and longevity infrastructure across APAC.
2 min read


The Longevity Tech Race: Why So Many Expensive Technologies End Up Gathering Dust
One of the most common frustrations I hear from leaders of luxury wellness resorts, longevity clinics and preventative health destinations is: "We bought all this expensive longevity technology…but we’re still waiting for the return." Ironically, many of these same businesses are also using that very technology as their primary differentiator.
Hyperbaric oxygen chambers, red light therapy beds, cryotherapy machines, advanced body composition scanners, AI-powered diagnostics…
5 min read


QAI Ventures: Deploying Quantum Infrastructure for the Future of Life Sciences
Executive Summary
The Event: Global venture capital firm QAI Ventures launches Singapore’s inaugural Quantum Accelerator in partnership with Enterprise Singapore, deploying an initial SGD 300,000 capital package per deep-tech venture.
The Thesis: Quantum computing represents the definitive backend infrastructure for the luxury longevity economy. The transition from basic discovery to biological engineering requires processing capacities capable of bypassing legacy lab
4 min read


The Horizons Dialogue with Jorge Lima
Jorge Lima is the architect behind the institutionalization of the longevity economy. As the Founder and CEO of the Longevity Med Summit, he serves as the primary nexus connecting clinical science, global capital, and the built environment. He is widely recognized as the preeminent strategist who has successfully dismantled the silos between healthcare and real estate, transforming "longevity" from a speculative medical category into a tangible, high-yield asset class that si
9 min read
bottom of page




